Hyponatremia in Hospitalized Patients: A Guide for Improving Patient Outcomes and Reducing Health-System Costs
Hyponatremia in Hospitalized Patients: A Guide for Improving Patient Outcomes and Reducing Health-System Costs
On-Demand Webcast
This webcast is based on live proceedings from the Pharmacy Learning Network 2012 Conference Series.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Presenters
Michael J. Cawley, PharmD, RRT, CPFT
Professor of Clinical Pharmacy
Philadelphia College of Pharmacy
University of the Sciences
Philadelphia, Pennsylvania
Mark A. Munger, PharmD, FCCP, FACC
Professor
Pharmacotherapy and Internal Medicine
Associate Dean, Academic Affairs, College of Pharmacy
The University of Utah
Salt Lake City, Utah
Intended Learners
This activity is designed for health-system pharmacists.
Learning Objectives
After completing this activity, participants should be able to:
- Describe the morbidity, mortality, and costs of mismanaged hyponatremia
- Outline the benefits and risks of current and emerging hyponatremia pharmacotherapies, including their use in patients with comorbid conditions
- Implement evidence-based management of hyponatremia to improve patient outcomes and reduce costs
Activity Overview
This on-demand webcast is available with synchronized slides and audio.
To be eligible for documentation of credit, participants must complete the educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
Release date: December 17, 2012
Expiration date: December 17, 2013
Estimated time to complete: 1 hour
There is no fee associated with this activity.
This educational activity is a knowledge-based activity.
For questions regarding this educational activity, please call 609-371-1137.
Hardware/Software Requirements
All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
Accreditation
In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CPE
This activity is approved for 1.0 contact hours (0.1 CEUs) of continuing pharmacy education (UAN 276-000-12-003-H01-P).
This educational activity is a knowledge-based activity.
Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at info@naccme.com. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Executive Director, Accreditation Services, NACCME, may be made for a second level of review.
Independent Clinical Reviewer: Randolph V. Fugit, PharmD, BCPS, Internal Medicine Clinical Specialist, Denver Veterans Affairs Medical Center, Clinical Assistant Professor, Clinical Pharmacy Practice, University of Colorado Health Sciences Center, Denver, Colorado
Planning Committee
The planning committee comprises Michael J. Cawley, PharmD, RRT, CPFT, Randolph V. Fugit, PharmD, BCPS, Mark A. Munger, PharmD, FCCP, FACC; and Kristin Ciszeski, Mary Johnson, Michael Kearney, Nick Lombardi, Randy Robbin, and John Savage, NACCME.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Cawley: Promotional speakers bureau—Cubist
Dr. Fugit: Consultant—Takeda Pharmaceuticals; Scientific advisor—Takeda Pharmaceuticals; Promotional speakers bureau—Astellas Pharma US, Inc, Takeda Pharmaceuticals
Dr. Munger disclosed no relevant financial relationships with any commercial interests.
Ms. Ciszeski, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.
Mr. Lombardi: Stock shareholder—Inspire Pharmaceuticals, Inc, Vertex Pharmaceuticals, Inc, ViroPharma, Inc
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty have disclosed that no off-label/unapproved uses of drugs and/or devices will be discussed in the presentations.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2012 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Grant Support
Supported by an educational grant from Otsuka America Pharmaceuticals, Inc.
